Search

Displaying results 8931 - 8940 of 10000 in total
  1. Drug

    MB07811

    go.drugbank.com/drugs/DB05192
    Investigational

    MB07811 is the first of a novel class of product candidates discovered by Metabasis designed to lower serum cholesterol and triglycerides. MB07811, a small molecule that is administered orally, has been extensively studied preclinically ...

  2. Drug

    Flovagatran

    go.drugbank.com/drugs/DB05714
    Experimental

  3. Drug

    LCP-AtorFen

    go.drugbank.com/drugs/DB05769
    Investigational

    LCP-AtorFen is a fixed-dose combination therapy for the treatment of high cholesterol levels combining atorvastatin (the active ingredient of Lipitor®) and the lowest dose of fenofibrate without food effect. LCP-AtorFen is designed to be...

  4. Drug

    CVT-6883

    go.drugbank.com/drugs/DB05936
    Experimental

    CVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation and fibrosis.

  5. Drug

    Amitifadine

    go.drugbank.com/drugs/DB05964
    Investigational

  6. Drug

    Thrombopoietin

    go.drugbank.com/drugs/DB06534
    Investigational

  7. Drug

    Estradiol sulfamate

    go.drugbank.com/drugs/DB06597
    Investigational

  8. Drug

    Ilepatril

    go.drugbank.com/drugs/DB06604
    Investigational

  9. Drug

    Otamixaban

    go.drugbank.com/drugs/DB06635
    Investigational

    Otamixaban is a novel direct Factor Xa (FXa) inhibitor. It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.

  10. Drug

    Clazosentan

    go.drugbank.com/drugs/DB06677
    Investigational